The Lyme Disease Biobank: Characterization of 550 Patient and Control Samples from the East Coast and Upper Midwest of the United States

Lyme disease (LD) is an increasing public health problem. Current laboratory testing is insensitive in early infection, the stage at which appropriate treatment is most effective in preventing disease sequelae. The Lyme Disease Biobank (LDB) collects samples from individuals with symptoms consistent...

Descripción completa

Detalles Bibliográficos
Autores principales: Horn, Elizabeth J., Dempsey, George, Schotthoefer, Anna M., Prisco, U. Lena, McArdle, Matthew, Gervasi, Stephanie S., Golightly, Marc, De Luca, Cathy, Evans, Mel, Pritt, Bobbi S., Theel, Elitza S., Iyer, Radha, Liveris, Dionysios, Wang, Guiqing, Goldstein, Don, Schwartz, Ira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Immunoassays
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269379/
https://www.ncbi.nlm.nih.gov/pubmed/32102853
http://dx.doi.org/10.1128/JCM.00032-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269379/
https://www.ncbi.nlm.nih.gov/pubmed/32102853
http://dx.doi.org/10.1128/JCM.00032-20

Ejemplares similares